HomeGERN • NASDAQ
add
Geron Corp
Nakaraang pagsara
$1.15
Sakop ng araw
$1.04 - $1.13
Sakop ng taon
$1.04 - $4.50
Market cap
689.06M USD
Average na Volume
7.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 49.04M | 5,459.64% |
Gastos sa pagpapatakbo | 38.56M | -2.17% |
Net na kita | -16.38M | 75.70% |
Net profit margin | -33.39 | 99.56% |
Kita sa bawat share | -0.02 | 80.00% |
EBITDA | -12.33M | 82.15% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 387.98M | 6.96% |
Kabuuang asset | 555.20M | 23.54% |
Kabuuang sagutin | 295.67M | 107.19% |
Kabuuang equity | 259.53M | — |
Natitirang share | 638.02M | — |
Presyo para makapag-book | 2.80 | — |
Return on assets | -5.57% | — |
Return on capital | -8.07% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -16.38M | 75.70% |
Cash mula sa mga operasyon | -27.42M | 48.74% |
Cash mula sa pag-invest | 20.32M | 156.20% |
Cash mula sa financing | 1.09M | -93.52% |
Net change in cash | -6.01M | 91.75% |
Malayang cash flow | -23.41M | 19.26% |
Tungkol
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Itinatag
1990
Headquarters
Website
Mga Empleyado
229
